文献速递皮肤肿瘤

角质形成细胞癌的表观遗传学改变

Epigenetic Alterations in Keratinocyte Carcinoma.
PubMed 文献 · J Invest Dermatol · 2020-11-16

该研究对11例接受Mohs手术患者的肿瘤-正常配对组织(5例基底细胞癌、6例鳞状细胞癌)进行H3K27ac修饰图谱分析,发现癌症特异性增强子及差异调控通路。BCC富集表皮发育和Wnt信号通路,SCC富集免疫应答和细胞活化通路,并优先验证了FGFR2增强子、FOXP1基因内调控及WNT5A启动子三个位点。

要点

  • BCC与SCC存在独特的H3K27ac增强子改变,提示表观遗传调控参与肿瘤分化。
  • BCC富集表皮发育及Wnt通路,SCC富集免疫应答及细胞活化通路。
  • 优先验证了FGFR2增强子(BCC)、FOXP1基因内调控(SCC)和WNT5A启动子(两亚型)的调控事件。

核心结论

  • 角质形成细胞癌存在独特和共享的组蛋白修饰表观遗传改变,可能影响BCC和SCC的分歧致癌通路。

研究设计与样本

  • 对11例接受Mohs手术患者的肿瘤-正常配对组织进行H3K27ac ChIP-seq分析,其中BCC 5例、SCC 6例。

主要发现

  • 基于配对样本间差异H3K27ac峰识别出癌症特异性增强子。
  • BCC中富集表皮发育和Wnt信号通路,SCC中富集免疫应答和细胞活化通路。
  • 转录因子富集分析提示SMAD和JDP2参与BCC发病,FOXP1参与SCC发病。
  • 优先验证了FGFR2增强子(BCC)、FOXP1基因内调控(SCC)和WNT5A启动子(两亚型)三个位点,并利用已发表基因表达数据验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are both derived from epidermal keratinocytes but are phenotypically diverse. To improve the understanding of keratinocyte carcinogenesis, it is critical to understand epigenetic alterations, especially those that govern gene expression. We examined changes to the enhancer-associated histone acetylation mark H3K27ac by mapping matched tumor-normal pairs from 11 patients (five with BCC and six with SCC) undergoing Mohs surgery. Our analysis uncovered cancer-specific enhancers on the basis of differential H3K27ac peaks between matched tumor-normal pairs. We also uncovered biological pathways potentially altered in keratinocyte carcinoma, including enriched epidermal development and Wnt signaling pathways enriched in BCCs and enriched immune response and cell activation pathways in SCCs. We also observed enrichment of transcription factors that implicated SMAD and JDP2 in BCC pathogenesis and FOXP1 in SCC pathogenesis. On the basis of these findings, we prioritized three loci with putative regulation events (FGFR2 enhancer in BCC, intragenic regulation of FOXP1 in SCC, and WNT5A promoter in both subtypes) and validated our findings with published gene expression data. Our findings highlight unique and shared epigenetic alterations in histone modifications and potential regulators for BCCs and SCCs that likely impact the divergent oncogenic pathways, paving the way for targeted drug discoveries.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Yao Q, Epstein CB, Banskota S, et al. Epigenetic Alterations in Keratinocyte Carcinoma. J Invest Dermatol. 2020. PMID: 33212152. doi:10.1016/j.jid.2020.10.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。